Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Rises By 115.9%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 22,041 shares, an increase of 115.9% from the June 30th total of 10,208 shares. Based on an average daily trading volume, of 9,029 shares, the short-interest ratio is currently 2.4 days. Approximately 0.8% of the shares of the company are short sold.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC grew its stake in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,739 shares of the company’s stock after acquiring an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 as of its most recent filing with the Securities and Exchange Commission.

F/m Emerald Life Sciences Innovation ETF Stock Down 0.2%

LFSC stock traded down $0.10 during midday trading on Tuesday, hitting $45.19. The stock had a trading volume of 2,933 shares, compared to its average volume of 4,763. F/m Emerald Life Sciences Innovation ETF has a 52 week low of $24.22 and a 52 week high of $47.68. The stock has a 50-day simple moving average of $42.33 and a 200 day simple moving average of $38.29.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.